Induced pluripotent stem cells: A new approach for physiological research

Cellular Physiology and Biochemistry

Volumn 26, Issue 2, 2010, Pages 105-124

  Pfannkuche, Kurt ^a   Hannes, Tobias ^a   Khalil, Markus ^a   Noghabi, Monireh Soroush ^b   Morshedi, Amir ^b   Hescheler, Jürgen ^a   Dröge, Peter ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Cardiovascular diseases; Embryonic stem cells; Induced pluripotent stem cells; iPS; Pluripotency; Reprogramming

Indexed keywords

CARDIOTONIC AGENT;

CELL DIFFERENTIATION; CELL FUSION; DISEASE MODEL; DRUG SCREENING; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION;

IPS;

EID: 78049327430     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320514     Document Type: Review

References (152)

1. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
2. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R: In vitro re-programming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324.
3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
4. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
5. Saric T, Frenzel L P, Hescheler J: Immu-nological barriers to embryonic stem cell-derived therapies. Cells Tissues Organs 2008;188:78-90.
6. Hyun I, Hochedlinger K, Jaenisch R, Yamanaka S: New advances in iPS cell research do not obviate the need for human embryonic stem cells. Cell Stem Cell 2007;1:367-368.
7. Gurdon JB, Melton DA: Nuclear repro-gramming in cells. Science 2008;322:1811-1815.
8. A NEW THEORY OF HEREDITY. Science 1884;3:388-390.
9. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KHS: Viable offspring derived from fetal and adult mammalian cells. Nature 1997;385:810-813.
10. Tada M, Tada T, Lefebvre L, Barton SC, Surani MA: Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 1997;16:6510-6520.
11. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T: Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001;11:1553-1558.
12. Yoshida I, Nishita Y, Mohandas TK, Takagi N: Reactivation of an inactive human X chromosome introduced into mouse embryonal carcinoma cells by microcell fusion with persistent expression of XIST. Exp Cell Res 1997;230:208-19.
13. Pells S, Di Domenico AI, Gallagher EJ, McWhir J: Multipotentiality of neuro-nal cells after spontaneous fusion with embryonic stem cells and nuclear repro-gramming in vitro. Cloning Stem Cells 2002;4:331-338.
14. Do JT, Scholer HR: Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 2004;22:941-949.
15. Cowan CA, Atienza J, Melton DA, Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005;309:1369-1373.
16. Tada M, Matsumura H, Kurose Y, Nakatsuji N, Tada T: Target chromosomes of inducible deletion by a Cre/in-verted loxP system in mouse embryonic stem cells. Chromosome Res 2009;17:443-450.
17. Matveeva NM, Pristyazhnyuk IE, Temirova SA, Menzorov AG, Vasilkova A, Shilov AG, Smith A, Serov OL: Unequal segregation of parental chromosomes in embryonic stem cell hybrids. Mol Reprod Dev 2005;71:305-314.
18. Nowak-Imialek M, Kues WA, Rudolph C, Schlegelberger B, Taylor U, Carnwath JW, Niemann H: Preferential loss of porcine chromosomes in reprogrammed interspecies cell hybrids. Cloning Stem Cells 2010;12:55-65.
19. Vasilkova AA, Kizilova HA, Puzakov MV, Shilov AG, Zhelezova AI, Golubitsa AN, Battulin NR, Vedernikov VE, Menzorov AG, Matveeva NM, Serov OL: Dominant manifestation of pluripotency in embryonic stem cell hybrids with various numbers of somatic chromosomes. Mol Reprod Dev 2007;74:941-951.
20. Dai B, Rasmussen TP: Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Stem Cells 2007;25:2567-2574.
21. Mayer W, Niveleau A, Walter J, Fundele R, Haaf T: Demethylation of the zygotic paternal genome. Nature 2000;403:501-502.
22. Razin A, Shemer R: DNA methylation in early development. Hum Mol Genet 1995;4 Spec No:1751-1755.
23. Razin A, Webb C, Szyf M, Yisraeli J, Rosenthal A, Naveh-Many T, Sciaky-Gallili N, Cedar H: Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci \USA 1984;81:2275-2279.
24. Zhu JK: Active DNA demethylation mediated by DNA glycosylases. Annu Rev Genet 2009;43:143-166.
25. Ooi SK, Bestor TH: The colorful history of active DNA demethylation. Cell 2008;133:1145-1148.
26. Kim JK, Samaranayake M, Pradhan S: Epigenetic mechanisms in mammals. Cell Mol Life Sci 2009;66:596-612.
27. Simonsson S, Gurdon J: DNA demethylation is necessary for the epi-genetic reprogramming of somatic cell nuclei. Nat Cell Biol 2004;6:984-990.
28. Hattori N, Imao Y, Nishino K, Hattori N, Ohgane J, Yagi S, Tanaka S, Shiota K: Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 2007;12:387-396.
29. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM: Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010;463:1042-147.
30. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK: Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem 2004;279:52353-52360.
31. Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le Grice S, McKay RD, Buetow KH, Gingeras TR, Misteli T, Meshorer E: Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008;2:437-447.
32. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T: Hy-perdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 2006;10:105-116. (Pubitemid 43025681)
33. Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, Ramalho-Santos J, McManus MT, Plath K, Meshorer E, Ramalho-Santos M: Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009;460:863-868.
34. Pfannkuche K, Summer H, Li O, Hescheler J, Droge P: The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells? Stem Cell Rev 2009;5:224-230.
35. Li E: Chromatin modification and epi-genetic reprogramming in mammalian development. Nat Rev Genet 2002;3:662-673.
36. Libertini LJ, Ausio J, van Holde KE, Small EW: Histone hyperacetylation. Its effects on nucleosome core particle transitions. Biophys J 1988;53:477-487.
37. Kimura H, Tada M, Nakatsuji N, Tada T: Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol Cell Biol 2004;24:5710-5720.
38. Ruau D, Ensenat-Waser R, Dinger TC, Vallabhapurapu DS, Rolletschek A, Hacker C, Hieronymus T, Wobus AM, Muller AM, Zenke M: Pluripotency associated genes are reactivated by chro-matin-modifying agents in neurosphere cells. Stem Cells 2008;26:920-926.
39. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-797.
40. Byrne JA, Nguyen HN, Reijo Pera RA: Enhanced generation of induced pluripo-tent stem cells from a subpopulation of human fibroblasts. PLoS One 2009;4:e7118.
41. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R: Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462:595-601.
42. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, Wahl GM, Belmonte JC: Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009;460:1140-1144.
43. Zhao Y, Yin X, Qin H, Zhu F, Liu H, Yang W, Zhang Q, Xiang C, Hou P, Song Z, Liu Y, Yong J, Zhang P, Cai J, Liu M, Li H, Li Y, Qu X, Cui K, Zhang W, Xiang T, Wu Y, Zhao Y, Liu C, Yu C, Yuan K, Lou J, Ding M, Deng H: Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008;3:475-479.
44. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K: A high-efficiency system for the generation and study of human induced pluripo-tent stem cells. Cell Stem Cell 2008;3:340-345.
45. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317.
46. Hotta A, Ellis J: Retroviral vector silencing during iPS cell induction: an epige-netic beacon that signals distinct pluripo-tent states. J Cell Biochem 2008;105:940-948.
47. Pfannkuche K, Fatima A, Gupta MK, Dieterich R, Hescheler J: Initial colony morphology-based selection for iPS cells derived from adult fibroblasts is substantially improved by temporary UTF1-based selection. PLoS One 2010;5:e9580.
48. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
49. Pesce M, Scholer HR: Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001;19:271-278.
50. Kopp JL, Ormsbee BD, Desler M, Rizzino A: Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008;26:903-911.
51. Rizzino A: Sox2 and Oct-3/4: A Versatile Pair of Master Regulators that Orchestrate the Self-renewal and Pluripotency of Embryonic Stem Cells by Functioning as Molecular Rheostats. Wiley Interdiscip Rev Syst Biol Med 2009;1:228-236.
52. Wadia JS, Stan RV, Dowdy SF: Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004;10:310-315.
53. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F: Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci \USA 2002;99:4489-4494.
54. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-476.
55. Pan C, Lu B, Chen H, Bishop CE: Repro-gramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC. Mol Biol Rep 2010;37:2117-2124.
56. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K: Induced pluripotent stem cells generated without viral integration. Science 2008;322:945-949.
57. Zhou W, Freed CR: Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009;27:2667-2674.
58. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M: Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009;85:348-362.
59. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K: Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009;458:771-775.
60. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A: piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-770.
61. Pelengaris S, Khan M, Evan G: c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002;2:764-776.
62. Rowland BD, Peeper DS: KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006;6:11-23.
63. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA: Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
64. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26:101-106.
65. Wernig M, Meissner A, Cassady JP, Jaenisch R: c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2:10-12.
66. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
67. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K: Reprogramming of neural progenitor cells into induced pluripo-tent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008;26:2467-2474.
68. Feng B, Jiang J, Kraus P, Ng JH, Heng JC, Chan YS, Yaw LP, Zhang W, Loh YH, Han J, Vega VB, Cacheux-Rataboul V, Lim B, Lufkin T, Ng HH: Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009;11:197-203.
69. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den BD, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Scholer HR: Oct4-induced pluripotency in adult neural stem cells. Cell 2009;136:411-419.
70. Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Scholer HR: Direct reprogramming of human neural stem cells by OCT4. Nature 2009;461:649-3.
71. Utikal J, Maherali N, Kulalert W, Hochedlinger K: Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 2009;122:3502-3510.
72. Heng JC, Feng B, Han J, Jiang J, Kraus P, Ng JH, Orlov YL, Huss M, Yang L, Lufkin T, Lim B, Ng HH: The nuclear receptor Nr5a2 can replace Oct4 in the repro-gramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010;6:167-174.
73. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA: Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008;26:1269-1275.
74. Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S, Hanna J, Lairson LL, Charette BD, Bouchez LC, Bollong M, Kunick C, Brinker A, Cho CY, Schultz PG, Jaenisch R: Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci \USA 2009;106:8912-8917.
75. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S: Induction of pluripo-tent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008;3:568-574.
76. Li W, Zhou H, Abujarour R, Zhu S, Young JJ, Lin T, Hao E, Scholer HR, Hayek A, Ding S: Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009;27:2992-3000.
77. Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, Chen T, Rao L, Chen S, Jia N, Dai H, Xin S, Kang J, Pei G, Xiao L: Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res 2008;18:600-603.
78. Tan SM, Wang ST, Hentze H, Droge P: A UTF1-based selection system for stable homogeneously pluripotent human embryonic stem cell cultures. Nucleic Acids Res 2007;35:e118.
79. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S: Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460:1132-1135.
80. Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S: A chemical platform for improved induction of human iPSCs. Nat Methods 2009;6:805-808.
81. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S: A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;2:525-528.
82. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, Blasco MA, Serrano M: The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009;460:1136-1139.
83. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A: Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55.
84. Melton C, Judson RL, Blelloch R: Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010;463:621-626.
85. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S: Hypoxia enhances the generation of induced pluripo-tent stem cells. Cell Stem Cell 2009;5:237-241.
86. Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, Pei D: Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010;6:71-79.
87. Shi Y, Zhao Y, Deng H: Powering repro-gramming with vitamin C. Cell Stem Cell 2010;6:1-2.
88. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Wang X, Wang L, Zeng F, Zhou Q: Efficient and rapid generation of induced pluripotent stem cells using an alternative culture medium. Cell Res 2010;20:383-386.
89. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE: Induced Pluripo-tent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures. Cell Stem Cell 2009;5:111-123.
90. Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R: The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 2007;45:482-486.
91. Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG: Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem 2009;284:30097-30104.
92. Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG: The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling. J Biol Chem 2008;283:33053-33058.
93. Lluis F, Pedone E, Pepe S, Cosma MP: Periodic activation of Wnt/beta-catenin signaling enhances somatic cell repro-gramming mediated by cell fusion. Cell Stem Cell 2008;3:493-507.
94. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M: Direct conversion of fibroblasts to functional neurons by defined factors.Nature 2010;463(7284):1031-2.
95. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA: In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008;455:627-632.
96. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den BS, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W: Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-816. (Pubitemid 47052190)
97. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA: Epigenetic status of human embryonic stem cells. Nat Genet 2005;37:585-587.
98. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA: Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum Mol Genet 2007;16 Spec No. 2:R243-R251.
99. Pick M, Stelzer Y, Bar-Nur O, Mayshar Y, Eden A, Benvenisty N: Clone-and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27:2686-2690.
100. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, Zhou Q: iPS cells produce viable mice through tetraploid complementation. Nature 2009;461:86-90.
101. Han J, Yuan P, Yang H, Zhang J, Soh BS, Li P, Lim SL, Cao S, Tay J, Orlov YL, Lufkin T, Ng HH, Tam WL, Lim B: Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 2010;463(7284):1096-100.
102. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-1923.
103. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U: Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008;118:507-517.
104. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK: Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008;118:498-506.
105. Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, Maclellan WR: Repro-grammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008;26:1537-1546.
106. Kuzmenkin A, Liang HM, Xu GX, Pfannkuche K, Eichhorn H, Fatima A, Luo HY, Saric T, Wernig M, Jaenisch R, Hescheler J: Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. Faseb J 2009;23:4168-4180.
107. Pfannkuche K, Liang H, Hannes T, Xi J, Fatima A, Nguemo F, Matzkies M, Wernig M, Jaenisch R, Pillekamp F, Halbach M, Schunkert H, Saric T, Hescheler J, Reppel M: Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell Physiol Biochem 2009;24:73-86.
108. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM: Embryonic Stem-Cells Differentiate In-Vitro Into Cardiomyocytes Representing Sinusnodal, Atrial and Ventricular Cell-Types. Mech Dev 1993;44:41-50.
109. Takahashi K, Okita K, Nakagawa M, Yamanaka S: Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007;2:3081-3089.
110. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L: Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells. Circulation 2009;120:1513-1523.
111. Zhang JH, Wilson GF, Soerens A G, Koonce CH, Yu JY, Palecek SP, Thomson JA, Kamp TJ: Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells. Circ Res 2009;104:E30-E41.
112. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ: Human embryonic stem cells develop into multiple types of cardiac myocytes-Action potential characterization. Circ Res 2003;93:32-39.
113. Caspi O, Itzhaki I, Arbel G, Kehat I, Gepstien A, Huber I, Satin J, Gepstein L: In Vitro Electrophysiological Drug Testing using Human Embryonic Stem Cell Derived Cardiomyocytes. Stem Cells Dev 2009;18(1):161-72.
114. Braam SR, Tertoolen L, van de SA, Meyer T, Passier R, Mummery CL: Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010;4:107-116.
115. Tanaka T, Tohyama S, Murata M, Nomura F, Kaneko T, Chen H, Hattori F, Egashira T, Seki T, Ohno Y, Koshimizu U, Yuasa S, Ogawa S, Yamanaka S, Yasuda K, Fukuda K: In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun 2009;385:497-502.
116. Reppel M, Pillekamp F, Lu ZJ, Halbach M, Brockmeier K, Fleischmann BK, Hescheler J: Microelectrode arrays: a new tool to measure embryonic heart activity. J Electrocardiol 2004;37 Suppl:104-109.
117. Satin J, Itzhaki I, Rapoport S, Schroder EA, Izu L, Arbel G, Beyar R, Balke CW, Schiller J, Gepstein L: Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 2008;26:1961-1972.
118. Antzelevitch C: Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem? J Electrocardiol 2004;37 Suppl:15-24.
119. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castella M, Rio P, Sleep E, Gonzalez F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surralles J, Bueren J, Belmonte JCI: Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009;460:53-59.
120. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ: Disease-specific induced pluripotent stem cells. Cell 2008;134:877-886.
121. Ye L, Chang JC, Lin C, Sun XF, Yu JW, Kan YW: Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci \USA 2009;106:9826-9830.
122. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221.
123. Ebert AD, Yu JY, Rose FF, Mattis VB, Lorson CL, Thomson JA, Svendsen CN: Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457:277-280.
124. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R: Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors. Cell. 2009;136:964-977.
125. Gussak I, Chaitman BR, Kopecky SL, Nerbonne JM: Rapid ventricular repolarization in rodents: Electrocardiographic manifestations, molecular mechanisms, and clinical insights. J Electrocardiol 2000;33:159-170.
126. Antzelevitch C: Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 2007;9 Suppl 4:iv4-15.
127. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, Sasse P, Rubenchik O, Fries JWU, Wenzel D, Geisen C, Xia Y, Lu ZJ, Duan YQ, Kettenhofen R, Jovinge S, Bloch W, Bohlen H, Welz A, Hescheler J, Jacobsen SE, Fleischmann BK: Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006;203:2315-2327.
128. Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, Stoecker E, Fleischmann M, Bohlen H, Stehle R, Kolossov E, Brem G, Addicks K, Pfitzer G, Welz A, Hescheler J, Fleischmann BK: Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002;105:2435-2441.
129. Pillekamp F, Reppel M, Rubenchyk O, Pfannkuche K, Matzkies M, Bloch W, Sreeram N, Brockmeier K, Hescheler J: Force measurements of human embryonic stem cell-derived cardiomyocytes in an in vitro transplantation model. Stem Cells 2007;25:174-180.
130. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu CH, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen YH, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnol 2007;25:1015-1024.
131. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L: Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardiol performance in infrcted rat hearts. J Am Coll Cardiol 2007;50:1884-1893.
132. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C, den Ouden K, Ward-van Oostwaard D, Korving J, Tertoolen LG, van Echteld CJ, Doevendans PA, Mummery CL: Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007;1:9-24.
133. Braam SR, Passier R, Mummery CL: Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 2009;30:536-545.
134. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A: Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells. Circulation 2009;120:408-416.
135. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK: Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007;450:819-824.
136. Freund C, Mummery CL: Prospects for Pluripotent Stem Cell-Derived Cardiomyocytes in Cardiac Cell Therapy and as Disease Models. J Cell Biochem 2009;107:592-599.
137. Evans MJ, Kaufman MH: Establishment in Culture of Pluripotential Cells from Mouse Embryos. Nature 1981;292:154-156.
138. Martin GR: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarci-noma stem cells. Proc Natl Acad Sci \USA 1981;78:7634-7638.
139. Vaags AK, Rosic-Kablar S, Gartley CJ, Zheng YZ, Chesney A, Villagomez DA, Kruth SA, Hough MR: Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential. Stem Cells. 2009;27:329-340.
140. Thomson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, Hearn JP: Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci \USA 1995;92:7844-7848.
141. Schwanke K, Wunderlich S, Reppel M, Winkler ME, Matzkies M, Groos S, Itskovitz-Eldor J, Simon AR, Hescheler J, Haverich A, Martin U: Generation and characterization of functional cardiomyocytes from rhesus monkey embryonic stem cells. Stem Cells 2006;24:1423-1432.
142. Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, Roybon L, Morizane A, Bergquist F, Riebe I, Nannmark U, Carta M, Hanse E, Takahashi J, Sasai Y, Funa K, Brundin P, Eriksson PS, Li JY: Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006;24:1433-1440.
143. Xie CQ, Zhang J, Xiao Y, Zhang L, Mou Y, Liu X, Akinbami M, Cui T, Chen YE: Transplantation of human undifferenti-ated embryonic stem cells into a myo-cardial infarction rat model. Stem Cells Dev 2007;16:25-29.
144. Xue T, Cho HC, Akar F G, Tsang S Y, Jones SP, Marban E, Tomaselli GF, Li RA: Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes-Insights into the development of cell-based pacemakers. Circulation 2005;111:11-20.
145. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gepstein L: Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nature Biotechnol 2004;22:1282-1289. (Pubitemid 39341201)
146. Esteban MA, Xu J, Yang J, Peng M, Qin D, Li W, Jiang Z, Chen J, Deng K, Zhong M, Cai J, Lai L, Pei D: Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem 2009;284:17634-17640.
147. Ezashi T, Telugu BPVL, Alexenko AP, Sachdev S, Sinha S, Roberts RM: Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci \USA 2009;106:10993-10998.
148. Wu Z, Chen J, Ren J, Bao L, Liao J, Cui C, Rao L, Li H, Gu Y, Dai H, Zhu H, Teng X, Cheng L, Xiao L: Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol 2009;1:46-54.
149. Li WL, Wei W, Zhu S Y, Zhu JL, Shi Y, Lin TX, Hao EG, Hayek A, Deng HK, Ding S: Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors. Cell Stem Cell 2009;4:16-19.
150. Liao J, Cui C, Chen SY, Ren JT, Chen JJ, Gao Y, Li H, Jia NN, Cheng L, Xiao HS, Xiao L: Generation of Induced Pluripo-tent Stem Cell Lines from Adult Rat Cells. Cell Stem Cell 2009;4:11-15.
151. Shimada H, Nakada A, Hashimoto Y, Shigeno K, Shionoya Y, Nakamura T: Generation of Canine-Induced Pluripo-tent Stem Cells by Retroviral Transduc-tion
152. Liu HS, Zhu FF, Yong J, Zhang PB, Hou PP, Li HG, Jiang W, Cai J, Liu M, Cui K, Qu XX, Xiang TT, Lu DY, Chi XC, Gao G, Ji WZ, Ding MX, Deng HK: Generation of Induced Pluripotent Stem Cells from Adult Rhesus Monkey Fibroblasts. Cell Stem Cell 2008;3:587-590.